Thromb Haemost 2003; 90(02): 245-251
DOI: 10.1160/TH03-01-0019
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

Fondaparinux and enoxaparin in comparison to unfractionated heparin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model

Axel Schlitt
,
Michael Buerke
,
Baerbel Hauroeder
1   Bundeswehrzentralinstitut der Bundeswehr Koblenz, Germany
,
Dirk Peetz
2   Clinic of Clinical Chemistry, Johannes Gutenberg-University Mainz, Germany
,
Ferdinand Hundt
3   Sanofi-Synthelabo, Berlin, Germany
,
Christoph Bickel
4   Bundeswehrzentralkrankenhaus der Bundeswehr Koblenz, Germany
,
Iris Schaefer
,
Juergen Meyer
,
Hans J. Rupprecht
› Author Affiliations

Financial support: This study was supported by grant from Sanofi–Synthelabo GmbH, Germany
Further Information

Publication History

Received 14 January 2003

Accepted after revision 14 May 2003

Publication Date:
06 December 2017 (online)

Preview

Summary

The aim of the present study was to investigate the efficacy of three different parenterally administered anticoagulants for the prevention of thrombus formation on artificial heart valves in an experimental rabbit model.

Unfractionated heparin was administered intravenously in group I (n = 10), Enoxaparin subcutaneously in group II (n = 10), fondaparinux intravenously in group III (n = 10), and no medication was administered to group IV (n = 9). Leaflets from Sulzer Carbomedics bileaflet mechanical heart valves were placed in a flow chamber. The flow chamber was filled with blood in a continuous circulation between the carotid artery and the jugular vein.

In group IV the flow chamber was clotted after a median of 15 minutes of circulation. Weight analysis before and after 1 h of perfusion showed that the median thrombus weight was 18.0 mg in group I, 17.7 mg in group II, 20.3 mg in group III, and 30.8 mg in group IV. Further analysis by electron microscopy showed similar results regarding deposition of fibrin, platelets, and erythrocytes on leaflet surfaces.

Fondaparinux and subcutaneously administered enoxaparin were as effective as intravenously administered unfractionated heparin in preventing thrombus formation on artificial heart valve leaflets in our investigation. This rabbit model, in which the heart valve leaflets were exposed to rabbit blood for a short time under laminar flow, should be further evaluated with respect to whether it can provide information about anti-thrombotic regimens in patients after mechanical heart valve replacement.